It’s Only Common Sense Mastering the Follow-Up—The Key to Closing More Deals
Driving Innovation: Registration in PCB Production Throughout the Process
Dan's Biz Bookshelf: 'Getting Naked: A Business Fable'
"Smart Capsule" is Potential New Drug-delivery Vehicle
July 15, 2015 | Purdue UniversityEstimated reading time: 2 minutes
A new "smart capsule" under development could deliver medications directly to the large intestines to target certain medical conditions.
"Usually, when you take medication it is absorbed in the stomach and small intestine before making it to the large intestine," said Babak Ziaie, a professor of electrical and computer engineering at Purdue University. "However, there are many medications that you would like to deliver specifically to the large intestine, and a smart capsule is an ideal targeted-delivery vehicle for this."
Such an innovation might be used to treat of irritable bowel syndrome, Crohn's disease and a potentially life-threatening bacterial infection called Clostridium difficile in which the body loses natural microorganisms needed to fight infection.
Findings are detailed in a research paper that appeared online and will be published in a future print issue of the Institute of Electrical and Electronics Engineers (IEEE) Transactions on Biomedical Engineering. The paper was authored by graduate students Wuyang Yu, Rahim Rahimi and Manuel Ochoa; Rodolfo Pinal, an associate professor of industrial and physical pharmacy; and Ziaie.
People are sometimes treated for C. difficile by transplanting feces from another person into the patient's large intestine, which provides vital microbes. However, it might be possible to convert the microbes into a powder through freeze-drying and deliver them with smart capsules instead, Ziaie said.
Researchers tested the smart capsule with a "fluidic model" that mimics the gastrointestinal tract and also using an experiment that recreates the changing acidity and peristalsis of the stomach and intestines as food passes through the digestive system.
"It takes up to 12 hours to get to the large intestine, so we wanted to make sure the smart capsule can withstand conditions in the gastrointestinal tract," Ziaie said.
The capsule is powered by a capacitor that is charged before use. A switch inside the capsule is activated by a magnet that could be worn on the patient's waist. As the capsule meanders through the intestines it eventually comes close to the magnet, activating the switch and releasing a spring-loaded mechanism that opens the capsule, which delivers the medication.
The prototype capsule is about the same size as a 000-size gelatin capsule and is designed to release the powdered medication just before reaching the ileocecal valve, where the small and large intestines meet.
The researchers have filed for a provisional U.S. patent through Purdue’s Office of Technology Commercialization of the Purdue Research Foundation.
The research is ongoing and is based at Purdue's Birck Nanotechnology Center. Future work may involve human patients.
Share on:
Suggested Items
Rules of Thumb: Design007 Magazine, November 2024
11/11/2024 | I-Connect007 Editorial TeamRules of thumb are everywhere, but there may be hundreds of rules of thumb for PCB design. They’re built on design formulas, fabricators’ limitations, and tribal knowledge. And unfortunately, some longtime rules of thumb should be avoided at all costs. How do we separate the wheat from the chaff, so to speak?
Connect the Dots: Best Practices for Prototyping
09/21/2023 | Matt Stevenson -- Column: Connect the DotsPCB prototyping is a critical juncture during an electronic device’s journey from concept to reality. Regardless of a project’s complexity, the process of transforming a design into a working board is often enlightening in terms of how a design can be improved before a PCB is ready for full production.
The Drive Toward UHDI and Substrates
09/20/2023 | I-Connect007 Editorial TeamPanasonic’s Darren Hitchcock spoke with the I-Connect007 Editorial Team on the complexities of moving toward ultra HDI manufacturing. As we learn in this conversation, the number of shifting constraints relative to traditional PCB fabrication is quite large and can sometimes conflict with each other.
Asia/Pacific AI Spending Surge to Reach a Projected $78 Billion by 2027
09/19/2023 | IDCAsia/Pacific spending on Artificial Intelligence (AI) ), including software, services, and hardware for AI-centric systems will grow to $78.4 billion in 2027, according to International Data Corporation's latest Worldwide Artificial Intelligence Spending Guide.
Intel to Sell Minority Stake in IMS Nanofabrication Business to TSMC
09/13/2023 | IntelIntel Corporation announced that it has agreed to sell an approximately 10% stake in the IMS Nanofabrication business to TSMC. TSMC’s investment values IMS at approximately $4.3 billion, consistent with the valuation of the recent stake sale to Bain Capital Special Situations.